Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000334286 | SCV000447355 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001548254 | SCV001768132 | uncertain significance | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV001548254 | SCV002367116 | likely benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278571 | SCV002567201 | uncertain significance | Connective tissue disorder | 2020-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348102 | SCV002653013 | likely benign | Cardiovascular phenotype | 2023-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004757216 | SCV005351521 | likely benign | PRDM5-related disorder | 2024-05-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |